Vivek Mehta, M.D., is a radiation oncologist at Swedish Cancer Institute, Seattle, and a new member of the ITN Editorial Advisory Board.


Radiation oncology is an important area of concentration for Imaging Technology News (ITN), as we provide coverage of radiation therapy technology, treatment planning solutions and data management systems specifically for radiation oncology.

As we strive to further strengthen our expertise in this field, I am honored to welcome Vivek Mehta, M.D., a radiation oncologist at Swedish Cancer Institute, Seattle, to the ITN Editorial Advisory Board.
Dr. Mehta joined Swedish Cancer Institute in 2002, and is actively involved in designing and developing clinical research studies at Swedish Cancer Institute and through national research organizations, including the Southwestern Oncology Group.

His clinical interests include image-guided radiotherapy, balloon catheter-based breast brachytherapy, gamma knife radiosurgery, intensity modulated radiotherapy, stereotactic radiosurgery, and three-dimensional conformal radiotherapy.

Dr. Mehta has been involved in a number of clinical research studies and has been widely published in medical journals and publications. He has written several articles evaluating the use of concurrent chemotherapy and radiation in the management of malignancy, which he also presented at national and international meetings. His research has appeared in the peer-reviewed International Journal of Radiation Oncology, Biology and Physics, the American Journal of Clinical Oncology, Archives of Surgery, and the Journal of Gastrointestinal Surgery.

A graduate of Georgetown University, Dr. Mehta earned his medical degree from the University of Washington and completed his internship at both the Legacy Good Samaritan Medical Center and Legacy Emanuel Hospital in Portland, Ore. He completed his residency at Stanford University Medical, where he also served as chief resident in the radiation oncology department. He is board certified in therapeutic radiology.

In 2004 and 2006, Seattle magazine named Dr. Mehta one of the city’s top doctors in the area of radiation oncology. Other accolades include numerous resident/fellow research awards, such as the Malcolm A. Bagshaw Radiation Oncology Resident Award. He is the current scientific program chair for the Washington State Radiation Oncology Society and is also active in the American Society of Therapeutic Radiation Oncologists, the American College of Radiology and the American Association of Indian Physicians, and the American Society of Clinical Oncology.
In addition to his work at the Swedish Cancer Institute, Dr. Mehta is an assistant clinical professor at the University of Washington School of Medicine. To contact Dr. Mehta, e-mail him at: [email protected]


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
Subscribe Now